Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CRON logo CRON
Upturn stock ratingUpturn stock rating
CRON logo

Cronos Group Inc (CRON)

Upturn stock ratingUpturn stock rating
$1.91
Last Close (24-hour delay)
Profit since last BUY-4.5%
upturn advisory
WEAK BUY
BUY since 29 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/18/2025: CRON (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -34.08%
Avg. Invested days 26
Today’s Advisory WEAK BUY
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/18/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 736.15M USD
Price to earnings Ratio 13.64
1Y Target Price 1.94
Price to earnings Ratio 13.64
1Y Target Price 1.94
Volume (30-day avg) 1934319
Beta 1.52
52 Weeks Range 1.60 - 2.54
Updated Date 06/18/2025
52 Weeks Range 1.60 - 2.54
Updated Date 06/18/2025
Dividends yield (FY) -
Basic EPS (TTM) 0.14

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 39.69%
Operating Margin (TTM) -10.9%

Management Effectiveness

Return on Assets (TTM) -2.42%
Return on Equity (TTM) 4.59%

Valuation

Trailing PE 13.64
Forward PE -
Enterprise Value -100751773
Price to Sales(TTM) 5.91
Enterprise Value -100751773
Price to Sales(TTM) 5.91
Enterprise Value to Revenue 0.02
Enterprise Value to EBITDA -1.42
Shares Outstanding 385419008
Shares Floating 204815522
Shares Outstanding 385419008
Shares Floating 204815522
Percent Insiders 46.73
Percent Institutions 14.32

Analyst Ratings

Rating 3.4
Target Price 1.94
Buy 1
Strong Buy 1
Buy 1
Strong Buy 1
Hold 2
Sell 1
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Cronos Group Inc

stock logo

Company Overview

overview logo History and Background

Cronos Group Inc. was founded in 2012, initially as PharmaCan Capital. It evolved into a globally diversified cannabis company with production and distribution across multiple continents. Significant milestones include becoming the first cannabis company to list on the Nasdaq and securing a major investment from Altria Group.

business area logo Core Business Areas

  • Hemp-Derived CBD: Focuses on producing and marketing hemp-derived CBD products, including tinctures, topicals, and edibles.
  • Cultivation and Production: Cultivates and produces cannabis and cannabis-derived products for recreational and medical markets.
  • Research and Development: Invests in research and development to create innovative cannabis products and technologies.

leadership logo Leadership and Structure

The leadership team comprises experienced professionals in the cannabis and consumer packaged goods industries. The organizational structure includes departments for cultivation, production, sales, marketing, and research and development.

Top Products and Market Share

overview logo Key Offerings

  • Peace Naturals: A brand of medical cannabis products. Market share information is difficult to pinpoint specifically, but Cronos operates in a highly competitive market with companies such as Tilray (TLRY) and Canopy Growth (CGC).
  • Spinach: A brand focused on the recreational cannabis market, known for its variety of strains. Exact market share data is difficult to ascertain. Competitors include Aurora Cannabis (ACB) and Organigram (OGI).
  • Lord Jones: A premium hemp-derived CBD brand. The CBD market is highly fragmented and competitive. Competitors include Charlotte's Web (CWBHF).

Market Dynamics

industry overview logo Industry Overview

The cannabis industry is experiencing growth and regulatory changes as more jurisdictions legalize cannabis for medical and recreational use. This includes the growth of CBD from hemp and the rise of cannabis-infused products.

Positioning

Cronos Group is positioned as a global cannabis company focused on premium brands and innovative product development. Its investment from Altria provides it with financial resources and expertise in regulated industries.

Total Addressable Market (TAM)

Estimates suggest the global cannabis market could reach hundreds of billions of dollars in the coming years. Cronos is attempting to capture a portion of this TAM by focusing on high-quality products and strategic partnerships.

Upturn SWOT Analysis

Strengths

  • Strong partnership with Altria Group (MO)
  • Global presence and distribution network
  • Focus on research and development
  • Diverse product portfolio
  • Strong brand recognition in certain markets

Weaknesses

  • Limited profitability and history of losses
  • High operating expenses
  • Dependence on regulatory changes
  • Relatively small market share compared to leading competitors
  • Concentrated in a few key markets

Opportunities

  • Expansion into new legal cannabis markets
  • Development of innovative cannabis products
  • Further penetration of existing markets
  • Strategic acquisitions and partnerships
  • Increase in global legalization

Threats

  • Intense competition in the cannabis industry
  • Regulatory uncertainty and changes
  • Fluctuations in cannabis prices
  • Potential for oversupply in the market
  • Negative public perception of cannabis

Competitors and Market Share

competitor logo Key Competitors

  • TLRY
  • CGC
  • ACB
  • OGI

Competitive Landscape

Cronos Group has a strategic advantage due to its partnership with Altria. However, competitors such as Tilray and Canopy Growth have greater market share and brand recognition in some markets.

Major Acquisitions

Lord Jones

  • Year: 2019
  • Acquisition Price (USD millions): 300
  • Strategic Rationale: To expand into the hemp-derived CBD market and leverage the brand's reputation for premium products.

Growth Trajectory and Initiatives

Historical Growth: Cronos Group has experienced revenue growth, driven by expanding cannabis markets and product innovation. However, growth has been uneven, and the company has not consistently achieved profitability.

Future Projections: Analyst estimates vary widely, reflecting the uncertainty of the cannabis industry. Future growth is expected to be driven by new markets and product categories.

Recent Initiatives: Recent initiatives include expanding production capacity, launching new products, and pursuing strategic partnerships.

Summary

Cronos Group benefits from a strategic partnership with Altria, providing financial strength and industry expertise, while operating in a high growth industry. However, they struggle with profits and face intense competition from companies with higher market share. Cronos needs to manage regulatory changes carefully as they continue to expand production capacity and launch new products.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company Filings (SEC), Analyst Reports, Market Research Reports

Disclaimers:

The data provided is for informational purposes only and should not be considered investment advice. Market share data is estimated and subject to change.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Cronos Group Inc

Exchange NASDAQ
Headquaters Stayner, ON, Canada
IPO Launch date 2016-07-12
President, CEO & Chairman Mr. Michael Ryan Gorenstein J.D.
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Full time employees 459
Full time employees 459

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada.